Trinity Biotech (TRIB) Inventory (2009 - 2025)

Trinity Biotech's Inventory history runs 17 years deep, the most recent figure standing at $18.8 million for Q4 2025.

• In Q4 2025, Inventory fell 2.82% year-over-year to $18.8 million; the TTM figure through Dec 2025 stood at $18.8 million (down 2.82% YoY), while the FY2025 annual figure was $18.8 million, down 2.82% from the prior year.
• Inventory came in at $18.8 million for Q4 2025 at Trinity Biotech, down from $20.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $37.6 million in Q1 2021 to a low of $1.2 million in Q4 2023.
• A 5-year average of $23.9 million and a median of $22.6 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory sank 94.85% in 2023 and surged 1570.17% in 2024, its largest moves.
• Trinity Biotech's Inventory stood at $29.1 million in 2021, then declined by 22.73% to $22.5 million in 2022, then tumbled by 94.85% to $1.2 million in 2023, then soared by 1570.17% to $19.4 million in 2024, then declined by 2.82% to $18.8 million in 2025.
• According to Business Quant data, Inventory over the past three periods registered $18.8 million, $20.1 million, and $19.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison